Eqis Capital Management, Inc. Biogen Inc. Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

A detailed history of Eqis Capital Management, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 1,865 shares of BIIB stock, worth $277,922. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,865

Previous 2,008 7.12%

Holding current value

$277,922

Previous $465,000 22.37%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $27,037 - $33,862	-143 Reduced 7.12%	1,865 $361,000
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $19,052 - $23,672	100 Added 5.24%	2,008 $465,000
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $7,420 - $9,369	-35 Reduced 1.8%	1,908 $411,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $40,956 - $49,300	-184 Reduced 8.65%	1,943 $502,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $62,311 - $70,328	-246 Reduced 10.37%	2,127 $546,000
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $187,995 - $217,234	-683 Reduced 22.35%	2,373 $675,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $40,793 - $46,482	-159 Reduced 4.95%	3,056 $849,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $126,472 - $153,666	501 Added 18.46%	3,215 $890,000
Q3 2022 Oct 24, 2022	BUY	$194.69 - $268.46 $17,132 - $23,624	88 Added 3.35%	2,714 $724,000
Q2 2022 Aug 08, 2022	SELL	$187.54 - $223.02 $7,501 - $8,920	-40 Reduced 1.5%	2,626 $535,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $21,508 - $27,099	-111 Reduced 4.0%	2,666 $562,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $4,254 - $5,467	-19 Reduced 0.68%	2,777 $666,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $584,374 - $762,088	-2,065 Reduced 42.48%	2,796 $791,000
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $21,497 - $34,420	-83 Reduced 1.68%	4,861 $1.68 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $9,475 - $11,100	39 Added 0.8%	4,944 $1.38 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $130,651 - $196,663	-553 Reduced 10.13%	4,905 $1.2 Million
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $241,999 - $279,418	-914 Reduced 14.34%	5,458 $1.55 Million
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $292,544 - $387,424	-1,131 Reduced 15.07%	6,372 $1.71 Million
Q1 2020 May 12, 2020	BUY	$268.85 - $341.04 $58,878 - $74,687	219 Added 3.01%	7,503 $2.54 Million
Q4 2019 Jan 24, 2020	BUY	$220.06 - $304.07 $31,468 - $43,482	143 Added 2.0%	7,284 $2.16 Million
Q3 2019 Nov 05, 2019	SELL	$217.44 - $243.88 $265,276 - $297,533	-1,220 Reduced 14.59%	7,141 $1.66 Million
Q2 2019 Jul 18, 2019	SELL	$219.29 - $241.72 $6,578 - $7,251	-30 Reduced 0.36%	8,361 $1.96 Million
Q1 2019 Apr 18, 2019	SELL	$216.71 - $338.96 $415,649 - $650,125	-1,918 Reduced 18.61%	8,391 $1.98 Million
Q4 2018 Jan 25, 2019	SELL	$278.5 - $352.75 $68,511 - $86,776	-246 Reduced 2.33%	10,309 $3.1 Million
Q3 2018 Oct 17, 2018	SELL	$293.51 - $383.83 $1.2 Million - $1.58 Million	-4,105 Reduced 28.0%	10,555 $3.66 Million
Q2 2018 Jul 27, 2018	BUY	$257.52 - $306.91 $2.21 Million - $2.64 Million	8,590 Added 141.52%	14,660 $4.26 Million
Q1 2018 Apr 06, 2018	SELL	$260.13 - $367.91 $286,663 - $405,436	-1,102 Reduced 15.37%	6,070 $1.66 Million
Q4 2017 Jan 25, 2018	BUY	$307.64 - $344.58 $133,515 - $149,547	434 Added 6.44%	7,172 $2.29 Million
Q3 2017 Oct 03, 2017	BUY	$281.15 - $329.69 $1.89 Million - $2.22 Million	6,738	6,738 $2.11 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account

Eqis Capital Management, Inc. Biogen Inc. Transaction History